Literature DB >> 20199633

Stopping tuberculosis in the 21st century: goals and strategies.

Ikushi Onozaki1, Mario Raviglione.   

Abstract

The Stop TB Strategy and the Global Plan to Stop TB were launched in 2006 to achieve the tuberculosis (TB)-related Millennium Development Goals and the Stop TB Partnership targets, and to address new challenges such as that of HIV-associated TB and multi-drug-resistant TB. This paper reviews the historical and recent progress in TB control to show what has changed since the introduction of directly observed therapy (DOTS) in the mid-1990s, why we needed the new strategy and what the global agenda is today. Major progress was seen in most countries in the last two decades. Globally, the estimated rates of TB prevalence and mortality are declining, but not quickly enough to reach the 2015 Stop TB Partnership targets of halving TB prevalence and death rates compared with 1990. In 2007, it was estimated that more than one-third of TB patients were not detected or properly treated under proper conditions. Enhancing case detection, while maintaining high treatment success rates, is essential to achieve the 2015 targets. The ultimate goal of TB control is the elimination of the disease as a public health problem. The Stop TB Partnership aims at eliminating TB by 2050 by reaching a global incidence of disease of less than one case per million population. This target will not be achieved unless TB control efforts are further intensified and effective and affordable new technologies to prevent both disease and infection are developed and rapidly introduced in all countries worldwide.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20199633     DOI: 10.1111/j.1440-1843.2009.01673.x

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  19 in total

Review 1.  Tuberculosis vaccines in clinical trials.

Authors:  Rosalind Rowland; Helen McShane
Journal:  Expert Rev Vaccines       Date:  2011-05       Impact factor: 5.217

2.  Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages.

Authors:  Anirudh Gairola; Aaron Benjamin; Joshua D Weatherston; Jeffrey D Cirillo; Hung-Jen Wu
Journal:  Adv Ther (Weinh)       Date:  2022-03-09

3.  Mycobacterium-Specific γ9δ2 T Cells Mediate Both Pathogen-Inhibitory and CD40 Ligand-Dependent Antigen Presentation Effects Important for Tuberculosis Immunity.

Authors:  Getahun Abate; Charles T Spencer; Fahreta Hamzabegovic; Azra Blazevic; Mei Xia; Daniel F Hoft
Journal:  Infect Immun       Date:  2015-12-07       Impact factor: 3.441

4.  Early detection of tuberculosis through community-based active case finding in Cambodia.

Authors:  Mao Tan Eang; Peou Satha; Rajendra Prasad Yadav; Fukushi Morishita; Nobuyuki Nishikiori; Pieter van-Maaren; Catharina Lambregts-van Weezenbeek
Journal:  BMC Public Health       Date:  2012-06-21       Impact factor: 3.295

Review 5.  Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review.

Authors:  Frank Cobelens; Sanne van Kampen; Eleanor Ochodo; Rifat Atun; Christian Lienhardt
Journal:  PLoS Med       Date:  2012-12-18       Impact factor: 11.069

6.  Pulmonary tuberculosis space-time clustering and spatial variation in temporal trends in Portugal, 2000-2010: an updated analysis.

Authors:  C Areias; T Briz; C Nunes
Journal:  Epidemiol Infect       Date:  2015-05-28       Impact factor: 4.434

7.  Proteins with complex architecture as potential targets for drug design: a case study of Mycobacterium tuberculosis.

Authors:  Bálint Mészáros; Judit Tóth; Beáta G Vértessy; Zsuzsanna Dosztányi; István Simon
Journal:  PLoS Comput Biol       Date:  2011-07-21       Impact factor: 4.475

8.  Evaluation of Tuberculosis Situation in Economic Cooperation Countries in 2009; Achievement and Gaps toward Millennium Development Goals.

Authors:  Ghobad Moradi; Kourosh Holakouie Naieni; Arash Rashidian; Parviz Vazirian; Ali Mirzazadeh; Mohammad Reza Pour Vaziri; Hossein Malek Afzali
Journal:  Int J Prev Med       Date:  2012-02

9.  Tuberculosis Infection in the United States: Prevalence Estimates from the National Health and Nutrition Examination Survey, 2011-2012.

Authors:  Roque Miramontes; Andrew N Hill; Rachel S Yelk Woodruff; Lauren A Lambert; Thomas R Navin; Kenneth G Castro; Philip A LoBue
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

10.  Population aging and migrant workers: bottlenecks in tuberculosis control in rural China.

Authors:  Sumedh Bele; Wei Jiang; Hui Lu; Hua You; Hong Fan; Lifang Huang; Qungang Wang; Hongbing Shen; Jianming Wang
Journal:  PLoS One       Date:  2014-02-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.